Drugs / FSH
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04157725 Background | Jun 2023 → Jan 2025 | infertility disorder, polycystic ovary syndrome | American University of Beirut Medical Center | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FSH | “followed by FSH/HMG (human menopausal gonadotropins) at a daily dose of 150-225 IU” NCT04157725 ↗ |